Toby O. Smith
Does flare trial design affect the effect size of non-steroidal anti-inflammatory drugs in symptomatic osteoarthritis? A systematic review and meta-analysis
Smith, Toby O.; Zou, Kun; Abdullah, Natasya; Chen, Xi; Kingsbury, Sarah R.; Doherty, Michael; Zhang, Weiya; Conaghan, Philip G.
Authors
Kun Zou
Natasya Abdullah
Xi Chen
Sarah R. Kingsbury
Michael Doherty
Professor WEIYA ZHANG WEIYA.ZHANG@NOTTINGHAM.AC.UK
PROFESSOR OF EPIDEMIOLOGY
Philip G. Conaghan
Abstract
Objectives: It is thought that the clinical trial benefits of oral non-steroidal anti-inflammatory drugs (NSAIDs) may relate to flare designs. The aim of this study was to examine the difference in NSAID (including cyclooxygenase-2 (COX-2) inhibitors) response in osteoarthritis (OA) trials based on different designs.
Methods: Systematic review was undertaken of the databases MEDLINE, EMBASE, AMED, CINAHL and the Cochrane library till February 2015. Randomised controlled trials assessing pain, function and/or stiffness following commencement of NSAIDs in flare and non-flare designs were eligible. Trials were assessed using the Cochrane Risk of Bias tool. Meta-analyses were conducted to assess the effect sizes (ES) of NSAIDs for OA with flare versus non-flare trial designs.
Results: Fifty-seven studies including 33 263 participants assessing 26 NSAIDs were included. Twenty-two (39%) were flare design, 24 (42%) were non-flare designs, 11 (19%) were possible flare designs. On meta-analysis, there was no statistically significant difference in ES of NSAIDs versus placebo between flare and non-flare trial designs for absolute pain and function or stiffness at immediate-term (1 week), short-term (2–4 week) or longer-term (12–13 week) follow-up periods (p>0.05). However there was a lower ES for mean change in pain in flare and possible flare trials compared with non-flare trials at short-term follow-up (0.36 vs 0.69; p=0.05).
Conclusions: Contrary to previous understanding, flare trial designs do not result in an increased treatment effect for NSAIDs in people with OA compared with non-flare design. Whether flare design influences other outcomes such as joint effusion remains unknown.
Citation
Smith, T. O., Zou, K., Abdullah, N., Chen, X., Kingsbury, S. R., Doherty, M., Zhang, W., & Conaghan, P. G. (2016). Does flare trial design affect the effect size of non-steroidal anti-inflammatory drugs in symptomatic osteoarthritis? A systematic review and meta-analysis. Annals of the Rheumatic Diseases, 75(11), https://doi.org/10.1136/annrheumdis-2015-208823
Journal Article Type | Article |
---|---|
Acceptance Date | Jan 23, 2016 |
Publication Date | Feb 18, 2016 |
Deposit Date | Apr 17, 2018 |
Print ISSN | 0003-4967 |
Electronic ISSN | 1468-2060 |
Publisher | BMJ Publishing Group |
Peer Reviewed | Peer Reviewed |
Volume | 75 |
Issue | 11 |
DOI | https://doi.org/10.1136/annrheumdis-2015-208823 |
Public URL | https://nottingham-repository.worktribe.com/output/1126433 |
Publisher URL | https://ard.bmj.com/content/75/11/1971 |
PMID | 26882928 |
You might also like
Association Between Hyperuricemia and Ultrasound-Detected Hand Synovitis
(2024)
Journal Article
Downloadable Citations
About Repository@Nottingham
Administrator e-mail: discovery-access-systems@nottingham.ac.uk
This application uses the following open-source libraries:
SheetJS Community Edition
Apache License Version 2.0 (http://www.apache.org/licenses/)
PDF.js
Apache License Version 2.0 (http://www.apache.org/licenses/)
Font Awesome
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2025
Advanced Search